• Explore /
  • Poster
  • / WINTHER: An international study to select rational therapeutics based on the analysis of matched tumor and normal biopsies in subjects with advanced malignancies.

WINTHER: An international study to select rational therapeutics based on the analysis of matched tumor and normal biopsies in subjects with advanced malignancies.

Abstract Poster

Authors

null

Jean-Charles Soria

Gustave Roussy Cancer Campus and University Paris-Sud, Villejuif, France

Jean-Charles Soria , Jordi Rodon Ahnert , Raanan Berger , Wilson H. Miller Jr., Irene Brana , Yohann Loriot , Tariq I Mughal , Vladimir Lazar , Fanny Wunder , Catherine Bresson , Serge Koscielny , Mohammad Afshar , Pierre Saintigny , Apostolia Maria Tsimberidou , Catherine Richon , Gerald Batist , Amir Onn , Aliza Ackerstein , Eitan Rubin , Razelle Kurzrock

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Tumor Biology

Track

Tumor Biology

Sub Track

New Targets and New Technologies

Clinical Trial Registration Number

NCT01856296

Citation

J Clin Oncol 35, 2017 (suppl; abstr TPS11625)

DOI

10.1200/JCO.2017.35.15_suppl.TPS11625

Abstract #

TPS11625

Poster Bd #

325a

Abstract Disclosures

Similar Posters

First Author: Andrea Botticelli

First Author: Ouissam Al Jarroudi

Poster

2011 ASCO Annual Meeting

A phase I clinical trial of QBI-139, a human ribonuclease variant, in solid tumors.

A phase I clinical trial of QBI-139, a human ribonuclease variant, in solid tumors.

First Author: L. E. Strong

First Author: Jifang Gong